Third Security, LLC Halozyme Therapeutics, Inc. Transaction History

Third Security, LLC

$241 Million
Q3 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$37.35 - $48.3 $6.03 Million - $7.8 Million	-161,452 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $227,576 - $291,444	-7,152 Reduced 4.24%	161,452 $6.49 Million
Q3 2021 Nov 10, 2021	SELL	$38.47 - $46.42 $37 Million - $44.6 Million	-960,947 Reduced 85.07%	168,604 $6.86 Million
Q1 2021 May 17, 2021	SELL	$39.51 - $51.45 $25 Million - $32.5 Million	-632,521 Reduced 35.9%	1,129,551 $47.1 Million
Q4 2020 Feb 16, 2021	SELL	$25.81 - $43.62 $31.7 Million - $53.5 Million	-1,226,460 Reduced 41.04%	1,762,072 $75.3 Million
Q3 2020 Nov 16, 2020	SELL	$25.74 - $29.63 $13.8 Million - $15.9 Million	-535,609 Reduced 15.2%	2,988,532 $78.5 Million
Q2 2020 Aug 10, 2020	SELL	$16.25 - $26.81 $57.3 Million - $94.5 Million	-3,524,141 Reduced 50.0%	3,524,141 $94.5 Million
Q1 2020 May 13, 2020	BUY	$13.9 - $21.83 $26,368 - $41,411	1,897 Added 0.03%	7,048,282 $127 Million
Q4 2019 Feb 03, 2020	SELL	$14.93 - $19.53 $39.7 Million - $51.9 Million	-2,659,702 Reduced 27.4%	7,046,385 $125 Million
Q3 2019 Nov 13, 2019	SELL	$15.2 - $17.69 $15.3 Million - $17.8 Million	-1,006,883 Reduced 9.4%	9,706,087 $151 Million
Q2 2019 Aug 09, 2019	SELL	$14.75 - $17.26 $49.9 Million - $58.3 Million	-3,379,801 Reduced 23.98%	10,712,970 $184 Million
Q3 2018 Nov 14, 2018	SELL	$16.68 - $18.41 $53.3 Million - $58.8 Million	-3,195,679 Reduced 18.48%	14,092,771 $256 Million
Q2 2018 Jul 30, 2018	SELL	$16.87 - $20.3 $5.13 Million - $6.18 Million	-304,321 Reduced 1.73%	17,288,450 $292 Million
Q3 2017 Nov 07, 2017	SELL	$11.76 - $17.4 $20.4 Million - $30.2 Million	-1,736,767 Reduced 8.99%	17,592,771 $306 Million
Q2 2017 Aug 09, 2017	BUY	N/A	19,329,538	19,329,538 $248 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$827 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$606 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$312 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$191 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$160 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.54B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Third Security, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Third Security, LLC with notifications on news.

Account